Is It Working? Evaluating The First Round Of Medicare Drug Price Negotiations.

In the short and longer terms, the Medicare Drug Price Negotiation Program should be evaluated based on four categories of outcomes: beneficiary access, prices and spending, promotion of value, and effects on innovation.